Do statins decrease the risk of colorectal cancer?

Hillmer, Melinda; Juurlink, David N.
September 2005
CMAJ: Canadian Medical Association Journal;9/27/2005, Vol. 173 Issue 7, p753
Academic Journal
Discusses research being done on statins and the risk of colorectal cancer. Reference to a study conducted by J. N. Poynter, S. B. Gruber, P. D. Higgins, R. Almog, J. D. Bonner, H. S. Rennert et al published in the 2005 issue of "New England Journal of Medicine"; Association of the statin use with lower risk of colorectal cancer; Influence of statins on physiologic processes independent of their effects on cholesterol levels.


Related Articles

  • Statins lose prevention ground.  // Nature Reviews Cancer;Jun2010, Vol. 10 Issue 6, p385 

    The article discusses the results of the Adenoma Prevention with Celecoxib (APC) trial which examined the efficacy of statins in cancer prevention. It references the study by Monica M. Bertagnolli and colleagues and Steven M. Lipkin and colleagues on the use of statin in colorectal adenoma...

  • Defining the Role of High-Dose Statins in PCI. Guarini, Giacinta; Marzilli, Mario // American Journal of Cardiovascular Drugs;Jun2013, Vol. 13 Issue 3, p189 

    Several studies have reported a significant reduction in morbidity and mortality in patients with acute coronary syndrome (ACS) or in patients with stable ischemic heart disease with the use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins). Based on these findings, current...

  • Pitavastatin in the Management of Hypercholesterolemia. Nomura, Shosaku // Clinical Medicine: Therapeutics;2009, Issue 1, p1477 

    Pitavastatin is an HMG-CoA reductase inhibitor that significantly reduces the plasma levels of total cholesterol, LDL-C and triglycerides, while also causing modest elevation of the plasma high-density cholesterol (HDL-C) level. This statin is minimally metabolized by the cytochrome P-450 (CYP)...

  • Statin Drugs Lower Artery Plague.  // Clarendon Enterprise (TX);2/15/2007, Vol. 18 Issue 9, p7 

    The article cites a study published in the Journal of American Medical Association stating that cholesterol lowering drugs, called statins, reduce the amount of plaque built up in the arteries.

  • New cholesterol guidelines support greater use of stains.  // Medical Marketing & Media;Jun2001, Vol. 36 Issue 6, p7 

    Focuses on the use of statins to lower cholesterol levels in the body. Recommendations for cholesterol lowering program; Effects of statin therapy on women; Importance in decreasing risk for chronic heart disease.

  • Antidote. Siegel, Marc // Medical Marketing & Media;Sep2010, Vol. 45 Issue 9, p12 

    The author reflects on the study that suggested the importance of statins in lowering cholesterol.

  • Keep Statins Coming. Harrar, Sari; J.M. // Prevention;Sep2002, Vol. 54 Issue 9, p164 

    Discusses the use of statin drugs to prevent heart attacks or death. Way that the drugs lower cholesterol; Idea that suddenly stopping the drug may reduce levels of nitric oxide on the blood.

  • Alzheimer Disease–No Target for Statin Treatment. A Mini Review. Siegfried Hoyer; Peter Riederer // Neurochemical Research;Apr2007, Vol. 32 Issue 4/5, p695 

    Abstract  Nosologically, Alzheimer disease (AD) is not a single disorder. A minority of around 400 families worldwide can be grouped as hereditary in origin, whereas the majority of all Alzheimer cases (approx. 25 million worldwide) are sporadic in origin. In the pathophysiology of the...

  • Improving adherence to statins by automated outreach.  // PharmacoEconomics & Outcomes News;1/12/2013, Issue 669, p6 

    The article discusses research being done on statins, referencing the study "Automated Outreach to Increase Primary Adherence to Cholesterol-Lowering Medications," by S. F. Derose et al. published in the November 26, 2012 issue of the "Archives of Internal Medicine."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics